GenMark Diagnostics (GNMK) Tops Q1 EPS by 1c

GenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $2.08 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c